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Background: Migration and invasion are hallmarks of cancer cells that allow their dissemination to other tissues.
Studying the cellular and molecular basis of cancer cell migration can help us to understand and control cancer
metastasis. Many membrane molecules have been described as being involved in tumor cell migration, and among
them is cholesterol.
Method: In the present study we investigated the role of membrane cholesterol in the migration of breast tumor
cells. The human mammary gland/breast epithelial cell line MDA-MB 231 was used and membrane cholesterol
was depleted with methyl-β-cyclodextrin (MbCD). Cell migration was measured in a cell-based scratch assay and
the involvement of the Wnt signaling was tested using Lef-1/TCF reporter activation in permanently transfected
MDA-MB 231 cells. Cell morphology was analyzed using fluorescent phalloidin to label F-actin structures.
Results: Our results show that membrane cholesterol depletion reduces cell migration, induces changes in cell
morphology and in membrane protrusions. Cholesterol depletion also induces an increase in the secretion of IL-10,
a cytokine involved in the control of cell migration. In addition, we show that these effects do not involve the
activation of the canonical Wnt/beta-catenin pathway. Interestingly, Wnt5a inhibited cell migration in similar levels
as MbCD, pointing to a role for the non-canonical Wnt pathway and IL-10 in this process.
Conclusion: Taken together, our results suggest a correlation between membrane cholesterol, non-canonical Wnt
signaling, IL-10 secretion and breast tumor cell migration. These results could contribute to the understanding of
breast tumor cell migration and may be used in the development of new therapeutic strategies targeted to breast
cancer metastasis.
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A breast tumor is composed of many different cells that
are present in the inner and the outer region of the tumor
mass. These cells are embedded in a complex extracellular
matrix, which contains many soluble factors. A minority of
these cells can undergo changes that enable then to mi-
grate to a blood vessel and then to other tissues during the* Correspondence: mermelstein@ufrj.br
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can initiate and control tumor cell migration are poorly
known. Understanding the molecular and cellular basis of
breast cancer metastasis is crucial for the development of
therapeutic strategies devoted to breast cancer treatment.
A variety of membrane proteins and lipids have been im-
plicated in the regulation of cancer cell adhesion and
migration, and cholesterol in particular, has been related
to several aspects of cancer pathology. Several studies
support that cholesterol content in tumor cells is higher
than in normal cells [1–5]. Transcriptional profiling byle is distributed under the terms of the Creative Commons Attribution 4.0
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significant overexpression of a number of genes involved in
the cholesterol biosynthetic pathway [6]. Cholesterol is an
integral component of cellular membranes, determines
membrane rigidity and fluidity, and plays a crucial role in
membrane organization, dynamics, and function [7]. In the
present study we investigated the possible role of mem-
brane cholesterol in the regulation of tumor cell migration.
We used the breast tumor cell line MDA-MB 231 to test
the effects of cholesterol depletion on cell migration. To de-
plete cholesterol from the plasma membrane we used the
substance methyl-β-cyclodextrin (MbCD), a compound
that has a hydrophobic cavity with a high affinity for choles-
terol [8, 9]. In the last years our group has shown that chol-
esterol depletion induces the release of Wnt molecules,
which in turn induces the proliferation and subsequent fu-
sion of cultured skeletal muscle cells [10, 11]. Here we
show that cholesterol depletion from MDA-MB 231 cells
result in a decrease in cell migration, which is accompanied
by changes in cell morphology and by the secretion of IL-
10. The knowledge of the role of membrane cholesterol in
the cellular response to migration could contribute to our
understanding of tumor cell migration and may be used in
the development of new therapeutic strategies targeted to
breast cancer metastasis.Methods
Cell cultures
This study using human cell lines was approved by the
Ethics Committee for Animal Care and Use in Scientific
Research from the Federal University of Rio de Janeiro.
All cell culture reagents were purchased from Invitrogen
(São Paulo, Brazil). The human mammary gland/breast
epithelial cell line MDA-MB 231 was obtained from the
American Type Culture Collection (ATCC® HTB-26™).
Cells were routinely grown in RPMI medium containing
10 % fetal bovine serum (FBS), 1 % L-glutamine and 1 %
penicillin-streptomycin, in a humidified 5 % CO2 atmos-
phere at 37 °C. Cells were cultured up to 70 %-100 %
confluence and then some cultures were treated with
the cholesterol depleting agent methyl-β-cyclodextrin
(MbCD, Sigma, USA) at different concentrations for 2 h.
After MbCD treatment, cultures were washed with fresh
cultured medium (RPMI with 2 % FBS) and grown in cul-
ture medium with 2 % FBS for the next 2 to 48 h. Some
cultures were grown in the presence of Wnt3a- or Wnt5a-
enriched medium, which was obtained respectively from
mouse Wnt3a or Wnt5a transfected L-cells. Other cells
were grown in the presence of the Wnt activator 6-
bromoindirubin-3'-oxime (Bio; Sigma) at a final concen-
tration of 5 M or with the Wnt inhibitor Dkk1 (recombin-
ant mouse Dkk1 protein; R&D Systems, USA) at a final
concentration of 0.1 mg/ml.Mouse L-cells culture and Wnt3a- and Wnt5a-conditioned
medium preparation
L-Wnt3a (ATCC® CRL-2647™) and L-Wnt5a cells (ATCC®
CRL-2814™) were cultured in DMEM supplemented with
10 % FBS and 0.4 mg/ml neomycin (Invitrogen) to main-
tain transgene expression during cell culture expansion.
Conditioned medium from L-Wnt3a and from L-Wnt5a
were collected as described below. Briefly, 1.3 x 106 cells
were plated in 75 cm2 culture flasks with 14 ml of medium
without antibiotics, and left to grow for four days. The
first batch of medium was collected and replaced with
14 ml of fresh medium for another three days. The second
batch of medium was then collected and the cells dis-
carded. Both batches were mixed, sterile-filtered (0.22 μm)
and stored at −20 °C for further assays.
Cell viability assay
Cell viability was determined using 3-(4,5-dimethyl-2-thia-
zyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) reagent
(Sigma). Briefly, cells were plated at an initial density of
2.5 x 104 cells per well in 96-well plates and incubated for
24 h at 37 °C under 5 % CO2. Twenty-four-h cultures were
treated with MbCD at a final concentration of 0.0001,
0.001, 0.01, 0.1, 0.5, 1, 2, 5 or 10 mM for 2 h. Cells treated
with medium only (RPMI medium containing 10 % FBS,
1 % L-glutamine and 1 % penicillin-streptomycin) served
as a negative control group. After 24 or 48 h of treatment,
the supernatant of each well was removed and cells were
washed twice with PBS. Then, 10 μl of MTT solution
(5 mg/ml in PBS) and 100 μl of medium were then added
to each well and incubated for 4 h at 37 °C, 5 % CO2. The
resultant formazan crystals were dissolved in dimethyl
sulfoxide (100 μl) and absorbance intensities were mea-
sured in a microplate reader (FlexStation® 3 Reader, Mo-
lecular Devices, USA) at 570 nm. All experiments were
performed in triplicate, and the relative cell viability (%)
was expressed as a percentage relative to the untreated
control cells.
Trypan blue exclusion assay
MbCD treated and non-treated cells were stained with
0.4 % trypan blue, and then examined microscopically to
determine the total number of cells and trypan blue
positive cells. The ratio of trypan blue positive cells was
calculated as following: [(the number of trypan blue
positive cells)/(the number of total cells)] × 100.
Plasma membrane integrity assay
To measure plasma membrane integrity, we assayed
serum lactate dehydrogenase (LDH) levels and calculated
percentages of LDH release to the medium. LDH activity
was measured spectrophotometrically using a commercial
kit (Doles, Goiás, Brazil). After MbCD treatment, 50 μl of
the supernatant were transferred to an enzymatic assay
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were added and incubated for 3 min at 37 °C, protected
from light. Then, 10 μl of NAD were added and absorb-
ance intensities were measured in a microplate reader
(FlexStation® 3 Reader, Molecular Devices, USA) at
490 nm. The percentage of LDH release was calculated by
([LDH] sample × 100)/total [LDH]. [LDH] sample was the
LDH level of the sample (released in medium) and total
[LDH] was the LDH content in the wells after addition of
lysis solution (0.9 % Triton X-100).
Lipid extraction and cholesterol determination
The liquid culture media from untreated and MbCD
treated cell cultures were collected after 2, 5, 8, 12, and
24 h after treatment for cholesterol determination. The
extraction started by adding 4 ml of chloroform:metha-
nol:HCl (2:1:0.075, v/v) and 1 ml of HCl 0.6 M to 1 ml
the samples in glass tubes, followed by agitation and
centrifugation (10 min, 300 x g). The organic phase (con-
taining the lipids) was collected and 1 ml of chloroform:-
methanol:HCl 0,6 M (3:48:47; v/v) was added, followed by
agitation and centrifugation (10 min, 300 x g). The final
organic phase from each sample was dried under N2 gas
and quantified gravimetrically. Cholesterol was deter-
mined according to the method described by Courchaine
et al. [12]. Briefly, the dried lipids from each sample in du-
plicate were solubilized in 750 μl of acetic acid, followed
by the addition of 500 μl of a color reagent (0.05 g FeCl3,
2 ml H3PO4, 23 ml H2SO4), vigorously homogenized in a
vortex mixer, and kept for 10 min at room temperature.
The absorbance of each sample was determined in a spec-
trophotometer (FlexStation® 3 Reader, Molecular Devices,
USA) at 550 nm. Cholesterol (Sigma) was used as the
standard. The results are expressed as mg cholesterol per
ml of sample. Aliquots (10 μl) from each sample were
used for protein determination by BCA reagent (Thermo
Scientific, USA), using bovine serum albumin as the
standard.
Cell-based scratch assay
Cells were cultured in 24-well culture plates for 24 h up
to 90 %-100 % confluence. Scratched wound lines on the
upside of cultured cells were created by 200 μl yellow
micropipette tip. The scratched cells were washed with
PBS after removal of culture media. The cells were
cultured for 2 h with 2 mM MbCD and after the removal
of culture media cells were cultured for the next 2, 8, 12
or 24 h. All cell-based scratch assays were performed in
the presence of the anti-mitotic reagent cytosine arabino-
side (ara-c; Sigma) at a final concentration of 10−5 M in
order to inhibit cell proliferation and analyze only cell mi-
gration. The wound area was measured from the image
taken with an Axiovert 100 microscope (Carl Zeiss,
Germany) by Image J program (NIH, USA) at 3 differentsites from each wound area of gaps. Three independent
experiments were performed.
F-actin labeling
Cells were rinsed with PBS and fixed with 4 % parafor-
maldehyde in PBS for 10 min at room temperature. Cells
were then permeabilized with 0.5 % Triton-X 100 in PBS
for 30 min. Cells were then washed in PBS for 30 min
and incubated with Texas Red Phalloidin (Molecular
Probes, USA) for 1 h at 37 °C. After incubation, cells
were washed for 30 min with PBS. Nuclei were labeled
with DAPI (4,6-Diamino-2-phenylindole dyhydrochlor-
ide; 0.1 μg/ml in 0.9 % NaCl) for 5 min. Cells were
mounted in ProLong Gold antifade reagent (Molecular
Probes) and examined with an Axiovert 100 microscope
(Carl Zeiss, Germany). Images were acquired with an
Olympus DP71 digital camera (Olympus, Japan).
Cell electroporation and luciferase assay
Electroporation was performed as previously described
[13]. Briefly, 2 x 106 MDA-MB 231 cells were ressus-
pended in 100 μl of electroporation buffer (5 mM KCl;
15 mM MgCl2; 120 mM Na2HPO4/NaH2PO4 pH 7.2;
25 mM Sodium Succinate; 25 mM Manitol) containing
4 μg of the reporter system plasmid 7xTcf-FFluc//SV40-
PuroR (7TFP, Addgene plasmid 24308) to evaluate the
activation of Wnt signaling [14] and 0.4 μg of TK-
Renilla plasmid (Promega, USA). The cells were immedi-
ately transferred to a sterile 0.2 cm cuvette (Mirus Bio-
tech®, USA) and electroporated using the program X-013
of the Lonza® Nucleofactor® II electroporation system.
After electroporation, cells were plated in 12-well plates
at an initial density of 105 cells/well and left to adhere
overnight at 37 °C and 5 % CO2. On the following day,
cultures were rinsed with PBS and incubated in tripli-
cates with 2 mM MbCD, 10 % Wnt3a-medium or 5 μM
Bio for 24 h. Cells were lysed with 80 μl of Reporter
Lysis buffer/well (Promega, USA) and processed to a
single freeze/thaw cycle at −80 °C to achieve complete
lysis. After a brief centrifugation at 4 °C, supernatants
were used to quantify luciferase activity through light
detection by luminometer (Glomax, Promega, USA)
after adding the Luciferase Assay Reagent according to
the manufacture’s protocol.
ELISA
The levels of IL-10 in cultured media were determined by
enzyme-linked immunosorbent assay (ELISA) protocol as
standardized by BD Biosciences (USA). Conditioned
media were collected from untreated cultures and after 2,
8 and 24 h of treatment with 2 mM MbCD or 10 %
Wnt3a or 10 % Wnt5a. Samples were centrifuged and the
supernatants used for measurement of the concentration
of IL-10. Briefly, the anti-mouse IL-10 capture monoclonal
Fig. 1 Cell viability analysis after MbCD-induced cholesterol depletion
in MDA-MB 231 cells. (a) A MTT-based method was used to analyze cell
viability in untreated and MbCD-treated cells. A significant decrease in
cell viability was observed 24 h and 48 h after treatment of cells with
10 mM of MbCD. MbCD treatment in the range between 0.0001 to 5
mM showed no effect on cell viability. (b) Measurements the serum
lactate dehydrogenase (LDH) levels in the culture medium were per-
formed to analyze plasma membrane integrity. MbCD treatment in the
range between 0.0001 to 5 mM of MbCD did not change LDH levels,
but 10 mM of MbCD induced an increase in the levels of LDH after
48 h of treatment. (c) Trypan blue exclusion assay was used to analyze
the number of viable cells. MbCD treatment in the range between
0.0001 to 2 mM of MbCD did not change LDH levels, but 5 and
10 mM of MbCD induced a decrease in the percentage of viable cells
after 24 h (only for 10 mM) and 48 h of treatment. Each bar represents
the mean and standard error of 3 independent experiments. *p < 0.05;
ANOVA versus control group
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polystyrene 96-well plate (Maxisorb, NUNC, Denmark),
and the IL-10 present in the sample was bound to the
antibody-coated wells. The recombinant mouse IL-10
(16 pg/ml to 0.125 pg/ml, R&D Systems, USA) was added
to standard wells. The biotinylated anti-mouse IL-10 de-
tecting mAb (0.1 μg/ml, R&D Systems, USA) was added to
bind the IL-10 captured by the first antibody. After wash-
ing, streptavidin-horseradish peroxidase (streptavidin-HRP,
Zymed, USA) was added to the wells to detect the biotinyl-
ated detecting antibody, and finally a Tetramethyl Benzi-
dine chromogenic solution (TMB, Zymed) was added as a
substrate, and a colored product formed in proportion to
the amount of IL-10 present in the samples was stopped
with HCl 1 N. Absorbance was read using 450 nm as wave-
length. All samples were analyzed in duplicate. Results of
cytokine concentration were expressed in pg/ml and were
mean of three different experiments.
Statistical analysis
All the values were represented as the mean ± standard
error. Statistical analysis was performed with one-way
ANOVA on Ranks with Newman-Keuls Post Hoc test
and statistical significance was defined as *p < 0.05 and
***p < 0.001.
Results and Discussion
To study the role of membrane cholesterol during the
migration of the breast tumor cell line MDA-MB 231,
we depleted cholesterol with the substance methyl-β-
cyclodextrin (MbCD). MbCD can selectively exclude
cholesterol from cell membranes [15] and thus it is pre-
sumed to change the membrane composition and struc-
ture, particularly the cholesterol-enriched membrane
microdomains. First, we analyzed the viability of the cells
after 24 and 48 h of treatment with different concentra-
tion of MbCD (from 0.0001 to 10 mM for 2 h). The
results of the MTT assay show that 0.0001 to 5 mM of
MbCD did not alter cell viability, but 10 mM of MbCD
reduced cell viability (Fig. 1a). We also analyzed the
plasma membrane integrity by measuring the serum lac-
tate dehydrogenase (LDH) levels in the culture medium.
Our data show that from 0.0001 to 5 mM of MbCD did
not change LDH levels, but 10 mM of MbCD induced
an increase in the levels of LDH (Fig. 1b). In addition,
trypan blue exclusion assay showed that only 5 and
10 mM of MbCD induced a decrease in the percentage
of viable cells (Fig. 1c). In agreement with our results,
Onodera and colleagues [16] have shown that 20 mM
MbCD (for 2 h) induces apoptosis in different tumor cell
lines. In conclusion, our results from cell viability
(MTT), plasma membrane integrity (LDH) and trypan
blue exclusion assays show that treatment of cells for
2 h with up to 2 mM of MbCD did not alter cell
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cell viability. Consistent with these results, our group
has previously shown that 2 mM of MbCD do not inter-
fere with cell viability in skeletal and cardiac muscle cells
grown in vitro [17, 18].
Then, we wanted to confirm the efficiency of MbCD
to induce cholesterol depletion in the membrane of
MDA-MB 231 cells. For this purpose, we estimated the
amount of cholesterol released in the culture media of
control and MbCD-treated cultures. Our results show a
3-fold increase in cholesterol concentration in the liquid
culture medium during the 2-h treatment with 2 mM
MbCD (Fig. 2a). After changing the medium containing
MbCD for a fresh one without the drug (5 h after MbCDFig. 2 Levels of cholesterol and proteins are enhanced in the cultured
media following treatment with MbCD in MDA-MB 231 cells. (a and b)
The amount of cholesterol and proteins was estimated in the following
conditions: growth medium immediately before MbCD treatment (0 h)
and at the end of MbCD treatment (2 h), as well as at 5, 8, 12 or 24 h
after treatment. Note a high increase in the amount of cholesterol
present in the culture medium only after 2 h of MbCD treatment, and
an increase in total protein levels only after 12 h of treatment. Each bar
represents the mean and standard error of 3 independent experiments.
*p < 0.05 and ***p < 0.001; ANOVA versus control group (0 hs)treatment in Fig. 2a), the levels of cholesterol in the li-
quid medium returned to values similar to the ones
found before MbCD treatment.
It has been demonstrated that MbCD extracts not only
cholesterol from plasma membranes, but also membrane
proteins [8]. So, we decided to analyze the amount of
proteins present in the MbCD-conditioned media. We
found a significant increase in the amount of proteins in
the conditioned media collected 12 h after MbCD treat-
ment (Fig. 2b), when compared to conditioned media
collected from untreated cultures (control). These data
suggest that MbCD induces the release and/or secretion
of proteins from the cells to the culture media. These
results are in agreement with our previous work showing
that MbCD induces the release of proteins in cultured
cells [11].
Since we found that treatment of MDA-MB 231 cells
with 2 mM of MbCD for 2 h was able to remove high
levels of cellular cholesterol without interfering with cell
viability (Figs. 1 and 2), we decided to use this concen-
tration of MbCD and duration of treatment for all the
subsequent experiments in order to deplete membrane
cholesterol and analyze its effects in cell migration.
Interestingly, we found that MbCD induces changes in
cell morphology. At the border of the scratched areas of
the culture dish, control cells displayed many ruffled
membranes and lamellipodia whereas in cholesterol de-
pleted cells membrane protrusions were less prominent
and most of the cells displayed a spindle shaped morph-
ology (Figs. 3 and 4). These differences are clearly
observed when cells were labeled with Phalloidin, which
stains filamentous actin (Figs. 3 and 4). Membrane pro-
trusions areas, such as ruffled membranes, lamellipodia
and filopodia, are usually filled with actin filaments,
which are known to interact with the plasma membrane.
Our results suggest that MbCD-induced cholesterol
depletion inhibits the formation and/or induces the re-
traction of membrane protrusions. We also found that
cholesterol depleted cells were less spread in the culture
dish and displayed an increase in the Z-axis as compared
to control cells (Fig. 4).
Next, we analyzed the effects of cholesterol depletion
in the migration of MDA-MB 231 cells. Cells were cul-
tured up to 90 %-100 % confluence and then scratched
wound lines were created by a micropipette tip. Some of
the scratched cultures were treated for 2 h with 2 mM
MbCD and then the culture media was removed and
cells were cultured for the next 8 or 24 h in fresh media
(without MbCD). Interestingly, untreated cells com-
pletely covered the scratched areas of the dish after 24 h
of culture while in MbCD-treated cultures it is possible
to see a relatively large empty area in the culture dish
after 24 h of treatment (Fig. 5). Quantification of the
shaved area showed that 60 % of the scratched area was
Fig. 3 Cholesterol depletion induces changes in cell morphology and in the distribution of actin filaments. MDA-MB 231 cells were grown for
24 h, scratched wound lines were created and cultures were treated with MbCD (b, d, f, h). Some cells were not treated (control, a, c, e, g). Cells
were analyzed 2 h after MbCD treatment by staining with the F-actin probe Texas red-Phalloidin (red, a, b, e, f) and the nuclear stain Dapi (blue,
a, b, e, f) and by phase contrast microscopy (c, d, g, h). Merged images shown with Phalloidin/Dapi labeling (a, b, e, f) are the same microscopic
fields as the ones shown under phase contrast microscopy (c, d, g, h). While the scratched area can be better appreciated on the low magnification
(a-d), the higher magnification images (e-h) illustrate more clearly the overall cell morphology. Note that control cells (a, c, e, g) display many ruffled
membranes and lamellipodia whereas in cholesterol depleted cells (b, d, f, h) membrane protusions were less prominent and most of the cells are
spindle-shaped. Scale bar in A represent 50 μm in (a-d), and scale bar in E represents 50 μm in (e-h)
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collection of these data shows that MbCD-induced chol-
esterol depletion inhibits cell migration in MDA-MB
231 cells. These results are in agreement with previous
observations that cholesterol or high-density lipoprotein
(HDL) treatments are able to stimulate MDA-MB 231
cell migration [19, 20] and with data showing that
MDA-MB-231 cells grown in lipid-depleted mediumresulted in an 85 % decrease in cell migration [21]. Raghu
and colleagues [22] showed that 10 mM MbCD inhibited
the migration of MDA-MB 231 cells with no interference
in cell viability.
In the last years our group has shown that membrane
cholesterol depletion induces the release of Wnt molecules
to the culture medium, which in turn induces the prolifer-
ation and differentiation of cultured skeletal muscle cells
Fig. 4 Details of cell morphology changes induced by cholesterol depletion. MDA-MB 231 cells were grown for 24 h and treated with MbCD
for 2 h. Control (a) and treated cells (b) were stained with the F-actin probe Texas red-Phalloidin (red) and the nuclear stain Dapi (blue).
To analyze the Z axis of the cells in culture, stained cells were visualized with a confocal microscope. A selected slice of the 16 μm stack, 1 μm
apart, is shown against the Y and Z section along the yellow line in the right and X and Z section in the bottom for control (c) and treated
(e) cultures. Note the increase in the Z-axis in treated cells. The lateral reconstruction for the control (d) and treated cultures (f) better illustrate
the increase in the Z-axis of treated cells. Scale bar in A represent 10 μm in (a, b), and scale bar in C represents 10 μm in (c, e)
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volvement of the Wnt/beta-catenin pathway in the reduc-
tion in cell migration observed after cholesterol depletion.
We analyzed the effects of Wnt3a and Bio, two activators
of the Wnt pathway, and Dkk-1, an inhibitor of the Wnt
pathway, in the migration of MDA-MB 231 cells. Quantifi-
cation of the shaved area showed that 70 % of the
scratched area was still empty after 24 h of Bio treatment,
whereas cells treated with Dkk-1 covered the scratched
area of the dish after 8 h of culture (Figs. 5 and 6). In
addition, we found that only 30 % of the shaved area was
clear of cells after 24 h of Wnt3a treatment (Fig. 6). Inter-
estingly, when added together, Dkk-1 could rescue part of
the inhibitory effects of MbCD in cell migration (Fig. 6).
These results suggest that the inhibition of MDA-MB 231
cell migration caused by MbCD-induced cholesterol de-
pletion is, at least partially, mediated by the Wnt pathway.
Our results show a minor inhibition of Wnt3a in the
migration of MDA-MB 231 cells. In contrast to our data,
Matsuda and colleagues [24] described that Wnt3a in-
creased the migratory ability of MDA-MB 231 cells in a
wound closure assay. The apparent discrepancy betweenour results and theirs could be attributed to their lack of
use of an anti-mitotic reagent (such as cytosine arabino-
side or mitomycin) to inhibit cell proliferation in the
wound closure assay. Wnt3a molecules have been shown
to have a proliferative role in many different cell types
and tissues [25]. Thus, the increased migratory ability of
MDA-MB 231 cells after exposure to Wnt3a observed
by Matsuda et al. [24] could be explained by an increase
in cell proliferation and not cell motility.
Since we found that the effect on migratory behavior
induced by MbCD treatment was similar to Bio (activator
of the Wnt pathway) and quite different from Dkk-1 (in-
hibitor of the Wnt pathway), and that Dkk-1 together with
MbCD could rescue part of the MbCD effects on cell
migration, we decided to observe the ability of MbCD
treatment to modulate the canonical Wnt/beta-catenin
pathway. To test this hypothesis we analyzed the effects of
MbCD, Bio and Wnt3a on Lef-1/TCF reporter activation
in permanently transfected MDA-MB 231 cells. Figure 7
shows significant Lef-1-responsive transcription of cells
treated with Wnt3a and Bio, but not with MbCD, which
luciferase activity values were similar to untreated cells
Fig. 5 Cholesterol depletion inhibits MDA-MB 231 cell migration. Cells were cultured up to 90 %-100 % confluence and then scratched wound lines were
created by a micropipette tip (0 h). Some of the scratched cultures were treated with MbCD, Bio, Wnt3a, Wnt5a, Dkk-1, or combinations with these molecules.
After 2 h of treatment the culture media were changed to MbCD-free fresh media and cells were analyzed by phase-contrast microscopy after 8 or 24 h of
treatment. Note that untreated cells (control) and cells treated with Dkk-1 completely covered the scratched areas of the dish after 24 h of culture while in
MbCD- and Bio-treated cultures it is possible to see a relatively large empty area in the culture dish after 24 h of treatment
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tion by MbCD do not activate the canonical Wnt/beta-ca-
tenin pathway in MBA-MB 231 cells.
Interestingly, quantification of the shaved area after 24 h
of Wnt5a treatment showed the same extent of cell migra-
tion as obtained for MbCD (Fig. 6), suggesting that MbCD
could be acting by a non-canonical Wnt pathway. The re-
sults with Wnt5a (Fig. 6) together with data showing that
the canonical Wnt/beta-catenin pathway is not involvedFig. 6 Cell migration is inhibited in a similar extent with MbCD and Bio, bu
and then scratched wound lines were created by a micropipette tip (0 h).
Wnt5a, Dkk-1, or combinations with these molecules. After 2 h of treatmen
media. Wound areas were quantified after 2, 12 and 24 h in each condition. N
treatment, while cells treated with Dkk-1 completely covered the scratched a
independent experiments(Fig. 7), lead us to hypothesize that the non-canonical
Wnt pathway could be involved in the inhibition of cell
migration observed after MbCD treatment.
Wnt5a activates the beta-catenin-independent Wnt
pathway, in which small G proteins, such as Rac and
Rho, and protein kinases, such as protein kinase C
(PKC) and Ca2+/calmodulin-dependent kinase (CaMK),
are involved [26]. The beta-catenin-independent path-
way is thought to regulate the cytoskeleton, therebyt not with Dkk-1. Cells were cultured up to 90 %-100 % confluence
Some of the scratched cultures were treated with MbCD, Bio, Wnt3a,
t with MbCD the culture media was changed to MbCD-free fresh
ote that 60 % of the scratched area was still empty after 24 h of MbCD
reas at the same time point. Each point represents the mean of 3
Fig. 7 Cholesterol depletion does not activate the canonical Wnt/
beta-catenin pathway. Lef-1-responsive transcription was accessed by
quantifying luciferase activity after treating Lef1-TCF-luciferase reporter
stably expressing MDA-MB 231 cells with 2 mM MbCD, Bio or Wnt3a for
24 h. Note the significant Lef-1-responsive transcription of cells treated
with Wnt3a and Bio, but not with MbCD, which luciferase activity values
were similar to untreated cells (control). Each bar represents the mean
and standard error of 3 independent experiments. ***p< 0.001; ANOVA
versus control group
Fig. 8 Cholesterol depletion enhances the levels of IL-10 in the cultured
media. IL-10 levels in conditioned media were measured by ELISA
revealing significantly higher levels of IL-10 in conditioned media
collected from 2 to 24 h after MbCD and Wnt5a treatment, when
compared to untreated cultures (0 h). All samples were analyzed in
triplicate and results of cytokine concentration were expressed in
pg/mL and were mean and standard error of three different experi-
ments. *p < 0.05 and ***p < 0.001; ANOVA versus control group (0 h)
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showing changes in the distribution of the actin cyto-
skeleton (Figs. 3 and 4), in cell polarity (Figs. 3 and 4)
and in cell migration (Figs. 5 and 6) after cholesterol
depletion is in agreement with the expected role of
Wnt5a.
It has been shown that Wnt5a, but not Wnt3a, in-
duces an increase in cytokine IL-10 production and se-
cretion in different cell types, such as mouse dendritic
cells and human macrophages [27, 28]. In addition, it
has been shown that IL-10 plays an inhibitory role in
epithelial cell migration [29]. So, we decided to analyze
the presence of IL-10 in the conditioned media after
cholesterol depletion and its possible involvement in the
inhibition of cell migration observed after MbCD treat-
ment. Interestingly, we found a significant increase in
the levels of the IL-10 in conditioned media collected 2,
8 and 24 h after MbCD treatment (Fig. 8). These results
are in agreement with our data results showing a signifi-
cant increase in the amount of proteins present in the
conditioned media collected after MbCD treatment
(Fig. 2). We also analyzed the effects of Wnt3a and
Wnt5a in the secretion of IL-10. In agreement with pre-
vious reports [27, 28], Wnt5a induced a significant in-
crease in IL-10 levels after 2, 8 and 24 h of treatment,
while Wnt3a did not induce IL-10 secretion (Fig. 8). The
increase in IL-10 levels after cholesterol depletion and
after Wnt5a treatment strengths our hypothesis that the
non-canonical Wnt pathway is involved in the inhibition
of cell migration observed after MbCD treatment. Sup-
porting these data, it has been shown that IL-10 sup-
presses tumor metastasis of human melanoma cells [30].We can suggest that the inhibition of MDA-MB 231 cell
migration induced by cholesterol depletion might be
mediated by Wnt5a and subsequent IL-10 secretion.
The collection of our results suggests the involvement
of membrane cholesterol in the control of protein secre-
tion that in turns regulates breast tumor cell migration.
How membrane cholesterol controls protein secretion is
not known. It has been shown that cholesterol depletion
by MbCD facilitates both redistribution of SNAP25 (syn-
aptosome-associated protein of 25 kDa) and sequential
exocytosis [31]. SNAP25 is a component of the SNARE
complex, which is involved in membrane fusion during
exocytosis. The authors hypothesized that cholesterol de-
pletion may facilitate the diffusion of SNAP25 protein
along the plasma membrane and thereby enhance the re-
distribution of SNAP25 into fused granules or that alter-
natively cholesterol depletion may alter properties of the
fusion pore. Interestingly, SNAP-25 is anchored to the
cytosolic face of membranes via palmitoyl side chains and
many effects of palmitoylation on modified proteins are
thought to reflect changes in association with cholesterol-
rich membrane domains [32, 33].
We have previously shown that cholesterol depletion
induces the release of Wnt molecules to the culture
medium in primary cultures of myoblast cells [10, 11].
Several Wnt proteins (such as Wnt-5a) are palmitoylated
and palmitoylated proteins are frequently targeted to
cholesterol-enriched membrane domains. Thus, in face
of our results we postulate that depletion of membrane
cholesterol could alter Wnt availability and release.
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Here we show for the first time a correlation between
membrane cholesterol, non-canonical Wnt signaling, IL-
10 secretion and breast tumor cell migration. Our re-
sults show that membrane cholesterol depletion reduces
cell migration, induces changes in cell morphology and
in membrane protrusions. Cholesterol depletion also in-
duces an increase in the secretion of IL-10. In addition,
we show that Wnt5a inhibited cell migration in similar
levels as MbCD, pointing to a role for the non-canonical
Wnt pathway and IL-10 in this process. These results
could contribute to the understanding of breast tumor cell
migration and may be used in the development of new
therapeutic strategies targeted to breast cancer metastasis.
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